GMED
GMED
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
22
$41.06M
Total Volume
$41.06M
41 transactions
Net Activity
$41.06M
Net selling
Sentiment Rating
Heavy DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Scavilla Daniel T
Pres, CEO
$15.85M total
Davidar David D
Dir
$7.57M total
Zarrilli Stephen T
Dir
$4.28M total
Huller Kelly
EVP, GC, Corporate Secretary
$4.06M total
Tobin James R
Dir
$2.24M total
Quick Actions
GMED has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at GMED (GMED) engaged in a total of 41 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 22 were sales. The total volume of insider trading reached $41.06M.
The net insider activity for GMED shows a net selling bias of $41.06M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Scavilla Daniel T (Pres, CEO), who traded 130.0K shares valued at $11.05M on Nov 21, 2024.
Globus Medical, Inc. (GMED) stock price, news, quote and history
Is Globus Medical (GMED) Still Undervalued Following Its Jefferies London Healthcare Conference Update?
Globus Medical (NYSE:GMED) Stock Forecast & Analyst Predictions
Globus Medical (GMED) Stock Gets Fair Value Trim After Mixed Analyst Revisions
Globus Medical, Inc. (GMED) Stock Forecasts
Globus Medical, Inc. (GMED) Stock Forecasts
FAQs About GMED Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for GMED.